Early atherosclerosis exhibits an enhanced procoagulant state
- PMID: 20697022
- DOI: 10.1161/CIRCULATIONAHA.109.907121
Early atherosclerosis exhibits an enhanced procoagulant state
Abstract
Background: Thrombin generation in vivo may be important in regulating atherosclerotic progression. In the present study, we examined for the first time the activity and presence of relevant coagulation proteins in relation to the progression of atherosclerosis.
Methods and results: Both early and stable advanced atherosclerotic lesions were collected pairwise from each individual (n=27) during autopsy. Tissue homogenates were prepared from both total plaques and isolated plaque layers, in which the activity of factors (F) II, X, and XII and tissue factor was determined. Microarray analysis was implemented to elucidate local messenger RNA synthesis of coagulation proteins. Part of each specimen was paraffin embedded, and histological sections were immunohistochemically stained for multiple coagulation markers with the use of commercial antibodies. Data are expressed as median (interquartile range [IQR]). Tissue factor, FII, FX, and FXII activities were significantly higher in early atherosclerotic lesions than in stable advanced atherosclerotic lesions. Endogenous thrombin potential and thrombin-antithrombin complex values consolidated a procoagulant profile of early atherosclerotic lesions (endogenous thrombin potential, 1240 nmol/L x min [IQR, 1173 to 1311]; thrombin-antithrombin complex, 1045 ng/mg [IQR, 842.6 to 1376]) versus stable advanced atherosclerotic lesions (endogenous thrombin potential, 782 nmol/L x min [IQR, 0 to 1151]; thrombin-antithrombin complex, 718.4 ng/mg [IQR, 508.6 to 1151]). Tissue factor, FVII, and FX colocalized with macrophages and smooth muscle cells. In addition, multiple procoagulant and anticoagulant proteases were immunohistochemically mapped to various locations throughout the atherosclerotic vessel wall in both early and advanced atherosclerotic stages.
Conclusions: This study shows an enhanced procoagulant state of early-stage atherosclerotic plaques compared with advanced-stage plaques, which may provide novel insights into the role of coagulation during atherosclerotic plaque progression.
Similar articles
-
Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.J Pathol. 1999 Jun;188(2):180-8. doi: 10.1002/(SICI)1096-9896(199906)188:2<180::AID-PATH338>3.0.CO;2-Q. J Pathol. 1999. PMID: 10398162
-
In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels.Thromb Haemost. 2000 Nov;84(5):904-11. Thromb Haemost. 2000. PMID: 11127875
-
Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.J Am Coll Cardiol. 2005 Aug 16;46(4):707-13. doi: 10.1016/j.jacc.2005.05.040. J Am Coll Cardiol. 2005. PMID: 16098440
-
Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.Clin Haematol. 1985 Jun;14(2):281-342. Clin Haematol. 1985. PMID: 2994929 Review.
-
Atherosclerosis: coagulation and fibrinolysis.Semin Thromb Hemost. 1998;24(3):255-60. doi: 10.1055/s-2007-995851. Semin Thromb Hemost. 1998. PMID: 9701457 Review.
Cited by
-
The many faces of the contact pathway and their role in thrombosis.J Thromb Thrombolysis. 2011 Jul;32(1):9-20. doi: 10.1007/s11239-011-0578-5. J Thromb Thrombolysis. 2011. PMID: 21404067 Review.
-
Association of sex and cardiovascular risk factors with atherosclerosis distribution pattern in lower extremity peripheral artery disease.Front Cardiovasc Med. 2023 Jun 27;10:1004003. doi: 10.3389/fcvm.2023.1004003. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37441701 Free PMC article.
-
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.J Thromb Haemost. 2021 Apr;19(4):1001-1017. doi: 10.1111/jth.15236. Epub 2021 Feb 10. J Thromb Haemost. 2021. PMID: 33421301 Free PMC article.
-
Role of tissue factor in atherothrombosis.Curr Atheroscler Rep. 2012 Oct;14(5):394-401. doi: 10.1007/s11883-012-0269-5. Curr Atheroscler Rep. 2012. PMID: 22886473 Free PMC article. Review.
-
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.Integr Biol (Camb). 2012 Jun;4(6):595-605. doi: 10.1039/c2ib00161f. Epub 2012 Apr 26. Integr Biol (Camb). 2012. PMID: 22534729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical